The largest database of trusted experimental protocols

Sensititre ast

Manufactured by Thermo Fisher Scientific
Sourced in France, United Kingdom

The Sensititre AST is a laboratory instrument designed for automated antimicrobial susceptibility testing (AST). It provides a standardized platform for determining the susceptibility of bacteria to various antimicrobial agents. The Sensititre AST automates the process of inoculating, incubating, and reading antimicrobial susceptibility tests, delivering reliable and consistent results.

Automatically generated - may contain errors

2 protocols using sensititre ast

1

Antimicrobial Susceptibility Testing for Multidrug-Resistant Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenotypic AST was performed using disc diffusion and Etest (meropenem) methods for A. baumannii. For CRE and CRAB isolates VITEK 2 (bioMerieux, France) and Sensititre AST was used (Thermo Fisher Scientific, UK). The AST panel included 42 (CRE) and 26 antimicrobials (CRAB) (belonging to 13 classes and 10 classes, respectively) (Table S1, available as Supplementary data at JAC-AMR Online). CLSI breakpoints were used for susceptibility interpretation.32 E. coli ATCC 25922 was used for quality control. In this study, isolates that were intermediately resistant to carbapenems were regarded as resistant.
+ Open protocol
+ Expand
2

Antimicrobial Resistance Profiling of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
From each sample solution, a volume of 10 μL was cultured on ECC agar (CHROMagar, France), a chromogenic medium allowing the detection of E. coli. One colony per sample showing typical E. coli morphology was selected. E. coli isolates were tested for their susceptibility to 11 antimicrobials belonging to eight classes by Sensititre AST (Thermo Fisher Scientific, UK) comprising colistin (polymyxins), cefpodoxime and ceftiofur (third-generation cephalosporins), azithromycin (macrolides), neomycin and streptomycin (aminoglycosides), amoxicillin (penicillins), enrofloxacin (quinolones), florfenicol (phenicols), doxycycline and oxytetracycline (tetracyclines). Potential production of ESBLs, as indicated by resistance to ceftiofur and/or cefpodoxime, was confirmed by double disc diffusion test according to the CLSI guidelines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!